Galectins role as predictive markers for anti-PD-1-based immunotherapy in non-small cell lung cancer.

被引：1
|
作者：
Capalbo, Carlo
Filetti, Marco
Scafetta, Giorgia
Marchetti, Paolo
Bartolazzi, Armando
机构：
[1] St Andrea Univ Hosp, Dept Med Oncol, Rome, Italy
[2] St Andrea Univ Hosp, Dept Oncol Pathol, Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 08期
关键词：
D O I：
10.1200/JCO.2019.37.8_suppl.111
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
111
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The Role of Cancer-Testis Antigens as Predictive and Prognostic Markers in Non-Small Cell Lung Cancer
    John, Thomas
    Starmans, Maud H. W.
    Chen, Yao-Tseng
    Russell, Prudence A.
    Barnett, Stephen A.
    White, Shane C.
    Mitchell, Paul L.
    Walkiewicz, Marzena
    Azad, Arun
    Lambin, Philippe
    Tsao, Ming-Sound
    Deb, Siddhartha
    Altorki, Nasser
    Wright, Gavin
    Knight, Simon
    Boutros, Paul C.
    Cebon, Jonathan S.
    PLOS ONE, 2013, 8 (07):
  • [22] Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations
    Dantoing, Edouard
    Piton, Nicolas
    Salaun, Mathieu
    Thiberville, Luc
    Guisier, Florian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [23] The progress and confusion of anti-PD1/PD-L1 immunotherapy for patients with advanced non-small cell lung cancer
    Zhang, Shuling
    Bai, Xueli
    Shan, Fengping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 80
  • [24] Avoiding Absolute Quantification Trap: A Novel Predictive Signature of Clinical Benefit to Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer
    Liu, Chengming
    Wang, Sihui
    Zheng, Sufei
    Xu, Fei
    Cao, Zheng
    Feng, Xiaoli
    Wang, Yan
    Xue, Qi
    Sun, Nan
    He, Jie
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [25] Response to PD-1-Based Immunotherapy for Non-Small Cell Lung Cancer Altered by Gut Microbiota
    Daqiang He
    Xing Li
    Rui An
    Lihong Wang
    Yun Wang
    Song Zheng
    Xueqing Chen
    Xianjun Wang
    Oncology and Therapy, 2021, 9 : 647 - 657
  • [26] Response to PD-1-Based Immunotherapy for Non-Small Cell Lung Cancer Altered by Gut Microbiota
    He, Daqiang
    Li, Xing
    An, Rui
    Wang, Lihong
    Wang, Yun
    Zheng, Song
    Chen, Xueqing
    Wang, Xianjun
    ONCOLOGY AND THERAPY, 2021, 9 (02) : 647 - 657
  • [27] Immunotherapy for Non-Small Cell Lung Cancer
    Yoon, Sung Ho
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2014, 77 (03) : 111 - 115
  • [28] Immunotherapy for non-small cell lung cancer
    Vafadar, Sam
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 37 - 42
  • [29] Immunotherapy in non-small cell lung cancer
    Peters, Geoffrey
    John, Thomas
    CANCER FORUM, 2018, 42 (01) : 24 - 28
  • [30] Immunotherapy for non-small cell lung cancer
    Kagamu, Hiroshi
    RESPIRATORY INVESTIGATION, 2024, 62 (02) : 307 - 312
12345